Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.50 |
| ▸ | P2RX4 | Q99571 | 7/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.36 |
| ▸ | PTPRC | P08575 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19038811 | 0.84 | AHR (0.39) | AHRPDE4B | |
| SCHEMBL26327426 | 0.81 | AHR (0.53) | AHRP2RX4PDE4BMAPTSMN1; SMN2 | |
| SCHEMBL17255944 | 0.79 | AHR (0.52) | AHRP2RX4PDE4BMAPTSMN1; SMN2 | |
| SCHEMBL31456928 | 0.79 | AHR (0.52) | AHRP2RX4PDE4BMAPTSMN1; SMN2 | |
| SCHEMBL28906607 | 0.79 | AHR (0.47) | AHRP2RX4PDE4BMAPTSMN1; SMN2 | |
| SCHEMBL19038787 | 0.79 | P2RX4 (0.45) | P2RX4PTPRCMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL15489935 | 0.77 | AHR (0.53) | AHRP2RX4PDE4BMAPTSMN1; SMN2 | |
| SCHEMBL24893448 | 0.77 | AHR (0.42) | AHRP2RX4MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL20208795 | 0.76 | AHR (0.52) | AHRP2RX4PDE4BMAPTSMN1; SMN2 | |
| SCHEMBL15470432 | 0.76 | AHR (0.52) | AHRP2RX4PDE4BMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170186962-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. | 2017-06-29 | — | — | US | disclosed |
| US-20170186962-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170186962-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS | H1-10, OR10J3, H1-0 | AHR 1851/4885P2RX4 1230/4885PDE4B 3973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.